CSI Market
Sign In | Register

Pulmatrix Inc (PULM) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PULM Annual Cash Flow →
Cash flow data covering Pulmatrix Inc–Dec 31 2024 offers a view into how Mar 31 2026's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
3 Months 		(Dec 31 2025) (Sep 30 2025) (Mar 31 2025) (Dec 31 2024)
Operating Activities
Income-1.17
Depreciation & amortization0.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Noncash Rent Expense-
Noncash Interest Expenses-
Fair Value Adjustment On Derivative Liability-
Non Cash Interest Expenses-
Amortization Of Operating Lease Rightofuse Asset-
Warrant Inducement Expense-
Operating Lease Right Of Use Asset Amortization Expense-
Increase Decrease In Operating Lease Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.38
Increase (Decrease) in Accrued Liabilities0.15
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.42
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-1.07
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock1.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-4.10
Investment From Related Party-
Proceeds From Issuance Of Common Stock And Warrants-
Proceeds From Extinguishment Of Debt And Repurchase Of Series Preferred Stock-
End Of Term Payments-
End Of Term Loan Payments-
Proceeds From Exercise Of Prefunded Warrants-
Proceeds From Issuance Of Preferred Stock And Common Stock-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations4.10
Proceeds From Issuance Of Preferred Stock And Common Stock Warrants Net Of Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-1.07
Total Cash Flow-0.07
4 historic quarters locked

Sign in to unlock the full Pulmatrix Inc cash flow history.

Sign In Create Free Account

About Pulmatrix Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-037594

Figures are derived from filed reports and may be restated. Historical data is subject to revision.